1. Home
  2. STKE vs RNXT Comparison

STKE vs RNXT Comparison

Compare STKE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STKE

Sol Strategies Inc.

HOLD

Current Price

$1.24

Market Cap

38.3M

Sector

N/A

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$2.39

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKE
RNXT
Founded
2002
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
42.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
STKE
RNXT
Price
$1.24
$2.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
192.3K
1.1M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
$552.94
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.85
$0.70
52 Week High
$7.75
$2.59

Technical Indicators

Market Signals
Indicator
STKE
RNXT
Relative Strength Index (RSI) 56.69 74.96
Support Level $1.15 $0.83
Resistance Level $1.40 N/A
Average True Range (ATR) 0.11 0.25
MACD 0.01 0.11
Stochastic Oscillator 72.37 78.91

Price Performance

Historical Comparison
STKE
RNXT

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: